Can case reports be used to identify trends in pelvic inflammatory disease? San Francisco, 2004-2009

Sexually Transmitted Diseases

Volumn 38, Issue 1, 2011, Pages 8-11

  Stephens, Sally C ^a,b   Bernstein, Kyle T ^a   Kohn, Robert P ^a   Klausner, Jeffrey D ^a   Philip, Susan S ^a  

^a SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AWARENESS; CHLAMYDIA; DEMOGRAPHY; DESCRIPTIVE RESEARCH; DISEASE SURVEILLANCE; FEMALE; FEMALE INFERTILITY; FISHER EXACT TEST; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PELVIC INFLAMMATORY DISEASE; PELVIS PAIN SYNDROME; RELIABILITY; SCREENING; SEXUALLY TRANSMITTED DISEASE; UNITED STATES;

ADULT; AMBULATORY CARE FACILITIES; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; DISEASE NOTIFICATION; FEMALE; GONORRHEA; HUMANS; INCIDENCE; PELVIC INFLAMMATORY DISEASE; POPULATION SURVEILLANCE; SAN FRANCISCO; SEXUALLY TRANSMITTED DISEASES; YOUNG ADULT;

EID: 78650821733     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3181e9afb1     Document Type: Article

References (22)

1. Centers for Disease Control and Prevention. Infertility Prevention Project. February 10, 2009. Available at: http://www.cdc.gov/std/ infertility/ipp.htm. Accessed May 6, 2009.
2. CDC "Dear Colleague: 29 January 2009". Available at http:// www.cdc.gov/std/general/dcl-1-29-2009.pdf. Accessed February 27 2009.
3. Fine D, Dicker L, Mosure D, Berman S, et al. Increasing chla-mydia positivity in women screened in family planning clinics: Do we know why? Sex Transm Dis 2008; 35:47-52.
4. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2007 Supplement, Chlamydia Prevalence Monitoring Project Annual Report 2007. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; January 2009.
5. Stamm WE. Chlamydia trachomatis infections of the adult. In: Holmes KK, Sparling PF, Stamm WE, et al, eds. Sexually Transmitted Disease, 4th ed. New York, NY: McGraw-Hill, 2008:575-594.
6. Paavonen J, Eggert-Kruse W. Chlamydia trachomatis: Impact on human reproduction. Hum Reprod 1999; 5:433-447.
7. Low N, Egger M, Sterne JA, et al. Incidence of severe reproductive tract complications associated with diagnosed genital chla-mydial infection: The Uppsala Women's Cohort Study. Sex Transm Infect 2006; 82:212-218.
8. Bakken IJ, Ghaderi S. Incidence of pelvic inflammatory disease in a large cohort of women tested for Chlamydia trachomatis: A historical follow-up study. BMC Infect Dis 2009; 9:130.
9. Paavonen J, Westrom L, Eschenbach D. Pelvic inflammatory disease. In: Holmes KK, Sparling PF, Stamm WE, et al, eds. Sexually Transmitted Disease, 4th ed. New York, NY: McGraw-Hill, 2008:1017-1050.
10. Haggerty CL, Totten PA, Astete SG, et al. Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease. Sex Transm Infect 2008; 84:338-342.
11. Council of State and Territorial Epidemiologists. CSTE State Re-portable Conditions Assessment (SRCA). Available at: http://www. cste.org/dnn/ ProgramsandActivities/PublicHealthInformatics/ StateReportableConditionsQueryResults/tabid/261/Default.aspx. Accessed April 20, 2009.
12. Sutton MY, Sternberg M, Zaidi A, et al. Trends in pelvic inflammatory disease hospital discharges and ambulatory visits, United States, 1985-2001. Sex Transm Dis 2005; 32:778-784.
13. Bohm MK, Newman L, Satterwhite CL, et al. Pelvic inflammatory disease among privately insured women, United States, 2001-2005. Sex Transm Dis 2010; 37:131-136.
14. Paik CK, Waetjen LE, Xing G, et al. Hospitalizations for pelvic inflammatory disease and tuboovarian abscess. Obstet Gynecol 2006; 107:611-616.
15. Moss NJ, Ahrens K, Kent CK, et al. The decline in clinical sequelae of genital Chlamydia trachomatis infection supports current control strategies. J Infect Dis 2006; 193:1336-1338; author reply 1338-1339.
16. Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Morb Mortal Wkly Rep Recomm Rep 2006; 55(RR-11):1-94.
17. Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep Recomm Rep 1997; 46(RR-10):1-55.
18. San Francisco Department of Public Health. San Francisco Sexually Transmitted Disease Annual Summary 2007. San Francisco, CA: San Francisco Department of Public Health, 2009.
19. Chow JM, Guo J, Sisco K,et al. Chlamydia and gonorrhea infection among female family planning clients diagnosed with pelvic inflammatory disease in California, 2003-2005. Presented at: 2008 CDC STD Prevention Meeting, March 10-13, 2008. Chicago, IL.
20. Simms I, Eastick K, Mallinson H, et al. Associations between Mycoplasma genitalium, Chlamydia trachomatis, and pelvic inflammatory disease. Sex Transm Infect 2003; 79:154-156.
21. Ness RB, Kip KE, Hillier SL, et al. A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease. Am J Epidemiol 2005; 162:585-590.
22. Wiesenfeld HC, Willard Cates J. Sexually transmitted disease and infertility. In: Holmes KK, Sparling PF, Stamm WE, et al, eds. Sexually Transmitted Disease, 4th ed. New York, NY: McGraw-Hill, 2008:1511-1527.